2004 - Fellow of the American Statistical Association (ASA)
Terry M. Therneau mostly deals with Internal medicine, Gastroenterology, Surgery, Pathology and Proportional hazards model. His Internal medicine study frequently draws parallels with other fields, such as Monoclonal gammopathy of undetermined significance. His research in Monoclonal gammopathy of undetermined significance focuses on subjects like Myeloma protein, which are connected to Malignancy.
His study in Gastroenterology is interdisciplinary in nature, drawing from both Liver transplantation and Transplantation. His Surgery research integrates issues from Epidemiology and Incidence. His Proportional hazards model research incorporates elements of Regression analysis and Econometrics.
His scientific interests lie mostly in Internal medicine, Gastroenterology, Surgery, Pathology and Liver transplantation. Terry M. Therneau studied Internal medicine and Oncology that intersect with Cancer. The various areas that Terry M. Therneau examines in his Gastroenterology study include Hepatocellular carcinoma and Survival analysis.
His work focuses on many connections between Hazard ratio and other disciplines, such as Proportional hazards model, that overlap with his field of interest in Retrospective cohort study. His studies in Multiple myeloma integrate themes in fields like Monoclonal gammopathy of undetermined significance, Bone marrow and Immunopathology. His Cohort study combines topics in areas such as Incidence, Cohort study and Risk factor.
His primary areas of investigation include Internal medicine, Oncology, Artificial intelligence, Dementia and Gastroenterology. His study involves Hepatocellular carcinoma, Cohort study, Hazard ratio, Cohort and Proportional hazards model, a branch of Internal medicine. In his research on the topic of Hepatocellular carcinoma, Severity of illness is strongly related with Liver transplantation.
His Cohort research is multidisciplinary, incorporating perspectives in Biomarker, Incidence and Risk factor. As part of the same scientific family, he usually focuses on Oncology, concentrating on Cancer and intersecting with Lower risk. Gastroenterology is closely attributed to Nonalcoholic fatty liver disease in his study.
His main research concerns Internal medicine, Magnetic resonance imaging, Alzheimer's disease, Biomarker and Incidence. His Internal medicine research includes themes of Gastroenterology, Monoclonal gammopathy of undetermined significance and Oncology. His Gastroenterology study focuses on Liver disease in particular.
Terry M. Therneau has included themes like Liver biopsy, Logistic regression and Surgery in his Magnetic resonance imaging study. His research integrates issues of Imaging biomarker and Biopsy in his study of Surgery. His Incidence research is multidisciplinary, relying on both Amyloidosis, AL amyloidosis, Rochester Epidemiology Project and Risk factor.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
The Cox Model
Terry M. Therneau;Patricia M. Grambsch.
Modeling Survival Data: Extending the Cox Model
Terry M. Therneau;Patricia M. Grambsch.
Proportional hazards tests and diagnostics based on weighted residuals
Patricia M. Grambsch;Terry M. Therneau.
A model to predict survival in patients with end‐stage liver disease
Patrick S. Kamath;Russell H. Wiesner;Michael Malinchoc;Walter Kremers.
Review of 1027 Patients With Newly Diagnosed Multiple Myeloma
Robert A. Kyle;Morie A. Gertz;Thomas E. Witzig;John A. Lust.
Mayo Clinic Proceedings (2003)
The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD
Paul Angulo;Jason M. Hui;Giulio Marchesini;Ellisabetta Bugianesi.
A long-term study of prognosis in monoclonal gammopathy of undetermined significance.
Robert A. Kyle;Terry M. Therneau;S. Vincent Rajkumar;Janice R. Offord.
The New England Journal of Medicine (2002)
Martingale-based residuals for survival models
Terry M. Therneau;Patricia M. Grambsch;Thomas R. Fleming.
An Introduction to Recursive Partitioning Using the RPART Routines
Terry M. Therneau;Elizabeth J. Atkinson.
Prevalence of Monoclonal Gammopathy of Undetermined Significance
Robert A. Kyle;Terry M. Therneau;S. Vincent Rajkumar;Dirk R. Larson.
The New England Journal of Medicine (2006)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: